Evidence map›Paper›PMID 32394308›Full record

ArticleMolecular biology reports2020

Transfer of healthy fibroblast-derived mitochondria to HeLa ρ

Amaneh Mohammadi Roushandeh, Kazuo Tomita, Yoshikazu Kuwahara, Ali Jahanian-Najafabadi, Kento Igarashi, Mehryar Habibi Roudkenar, Tomoaki Sato

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Review
  3. Journal of dental sciences · 2026
    Article
  4. Review
  5. Review
  6. Modified TPP-MoSNeurology international · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Amaneh Mohammadi Roushandeh *Medical Biotechnology Department, Paramedicine faculty, Guilan University of Medical Sciences, Rasht, Iran.
Kazuo Tomita *Department of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Yoshikazu KuwaharaDivision of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Ali Jahanian-NajafabadiDepartment of Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
Kento IgarashiDepartment of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Mehryar Habibi RoudkenarMedical Biotechnology Department, Paramedicine faculty, Guilan University of Medical Sciences, Rasht, Iran. roudkenar@gums.ac.ir.ORCID http://orcid.org/0000-0001-8364-7245
Tomoaki SatoDepartment of Applied Pharmacology, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
Kagoshima University · JPIsfahan University of Medical Sciences · IRTohoku Medical and Pharmaceutical University · JP

Funding

Guilan University of Medical Sciences IR.GUMS.REC.1397.35Japan Society for the Promotion of Science 19K10318
6 · The paper itself

Abstract

Mitochondrial dysfunction is known to contribute to cancer initiation, progression, and chemo-and radio-resistance. However, the precise role of mitochondria in cancer is controversial. Hence, here we tried to further clarify the role of mitochondria in cancer by transferring healthy mitochondria to cancer cells, and also to cells with depleted mitochondrial DNA (ρ

Indexed as

ApoptosisCaspase 9Cell Line, TumorCell ProliferationCisplatinFibroblastsHeLa CellsHumansMembrane Potential, MitochondrialMitochondriaNeoplasmsProto-Oncogene Proteins c-bcl-2Caspase 9CisplatinProto-Oncogene Proteins c-bcl-2ApoptosisCancerChemoresistanceCisplatinMitochondria transfer

Identifiers

PMID32394308
OpenAlexW3025653846

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.